235 related articles for article (PubMed ID: 19506396)
21. Metabolic implications of growth hormone therapy.
Perrini S; Carreira MC; Conserva A; Laviola L; Giorgino F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):79-84. PubMed ID: 19020393
[TBL] [Abstract][Full Text] [Related]
22. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
Holmer H; Ekman B; Björk J; Nordstöm CH; Popovic V; Siversson A; Erfurth EM
Eur J Endocrinol; 2009 Nov; 161(5):671-9. PubMed ID: 19667040
[TBL] [Abstract][Full Text] [Related]
23. Replacement therapy and cardiovascular diseases.
Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
[TBL] [Abstract][Full Text] [Related]
24. Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.
Yuen KCJ; Mattsson AF; Burman P; Erfurth EM; Camacho-Hubner C; Fox JL; Verhelst J; Geffner ME; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):768-777. PubMed ID: 29029108
[TBL] [Abstract][Full Text] [Related]
25. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences.
Bannink EM; van der Palen RL; Mulder PG; de Muinck Keizer-Schrama SM
Horm Res; 2009; 71(6):343-9. PubMed ID: 19506392
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone deficiency after traumatic brain injury in adults: when to test and how to treat?
Kelestimur F
Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():534-9. PubMed ID: 19550389
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone replacement therapy improves hypopituitarism-associated hypoxemia in a patient after craniopharyngioma surgery: A case report.
Qi W; Gu F; Wu C
Medicine (Baltimore); 2019 Jan; 98(3):e14101. PubMed ID: 30653131
[TBL] [Abstract][Full Text] [Related]
29. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
30. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
Scaroni C; Ceccato F; Rizzati S; Mantero F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
[TBL] [Abstract][Full Text] [Related]
31. Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy.
Liu AK; Bagrosky B; Fenton LZ; Gaspar LE; Handler MH; McNatt SA; Foreman NK
Pediatr Blood Cancer; 2009 Feb; 52(2):227-30. PubMed ID: 18937328
[TBL] [Abstract][Full Text] [Related]
32. Craniopharyngioma radiotherapy: endocrine and cognitive effects.
Merchant TE
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():439-46. PubMed ID: 16700322
[TBL] [Abstract][Full Text] [Related]
33. Update from the GHMonitorSM observational registry in children treated with recombinant human growth hormone (Saizen).
Plotnick L; Rapaport R; Desrosiers P; Fuqua JS
Pediatr Endocrinol Rev; 2009 Jan; 6 Suppl 2():278-82. PubMed ID: 19337182
[TBL] [Abstract][Full Text] [Related]
34. Acute pancreatitis following naproxen intake.
Aygencel G; Akbuga B; Keles A
Eur J Emerg Med; 2006 Dec; 13(6):372. PubMed ID: 17091064
[TBL] [Abstract][Full Text] [Related]
35. [Severe generalized dystonia due to postradiotherapy cerebral calcifications].
Chanson JB; Anheim M; Lagha-Boukbiza O; Fleury M; Sellal F; Tranchant C
Rev Neurol (Paris); 2008 May; 164(5):477-80. PubMed ID: 18555882
[TBL] [Abstract][Full Text] [Related]
36. Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism.
Gilliland T; Dufour S; Shulman GI; Petersen KF; Emre SH
Pediatr Transplant; 2016 Dec; 20(8):1157-1163. PubMed ID: 27762491
[TBL] [Abstract][Full Text] [Related]
37. Childhood Craniopharyngioma: A 22-Year Challenging Follow-Up in a Single Center.
Tosta-Hernandez PDC; Siviero-Miachon AA; da Silva NS; Cappellano A; Pinheiro MM; Spinola-Castro AM
Horm Metab Res; 2018 Sep; 50(9):675-682. PubMed ID: 29959763
[TBL] [Abstract][Full Text] [Related]
38. Intracavitary chemotherapy of polycystic craniopharyngioma with bleomycin.
Savas A; Arasil E; Batay F; Selcuki M; Kanpolat Y
Acta Neurochir (Wien); 1999; 141(5):547-8; discussion 549. PubMed ID: 10392216
[No Abstract] [Full Text] [Related]
39. [Hypopituitarism mode in patients with craniopharyngioma in relation to tumor growth pattern].
Qi ST; Peng JX; Pan J; Fan J; Zhang SC; Liu Y; Bao Y; Qiu BH; Wu XY
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(1):19-24. PubMed ID: 29343024
[No Abstract] [Full Text] [Related]
40. Growth hormone therapy in boy with panhypopituitarism may induce pilomatricoma recurrence: case report.
Oswiecimska JM; Ziora KT; Ziora KN; Pindycka-Piaszczynska M; Zajecki W; Pikiewicz-Koch A; Stojewska M
Neuro Endocrinol Lett; 2008 Feb; 29(1):51-4. PubMed ID: 18283258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
